Quest Diagnostics Incorporated (DGX) — Financial statements
Income statement, balance sheet, and cash flow for Quest Diagnostics Incorporated — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 11,035↑11.8% | 9,872↑6.7% | 9,252↓6.4% | 9,883↓8.4% | 10,788 | |
| Cost of Revenue | 7,512↑13.3% | 6,628↑6.9% | 6,199↓3.9% | 6,450↓2.0% | 6,579 | |
| Gross Profit | 3,523↑8.6% | 3,244↑5.7% | 3,069↓10.6% | 3,433↓18.4% | 4,209 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 1,967↑11.1% | 1,770↑9.6% | 1,615↓13.8% | 1,874↑8.5% | 1,727 | |
| Other Expenses | -47↓136.7% | 128↓33.3% | 192↑46.6% | 131↑29.7% | 101 | |
| Operating Expenses | 1,920↑1.2% | 1,898↑5.0% | 1,807↓9.9% | 2,005↑9.7% | 1,828 | |
| Total Costs & Expenses | 9,432↑10.6% | 8,526↑6.7% | 7,990↓5.5% | 8,455↑0.6% | 8,407 | |
| Operating Results | ||||||
| Operating Income | 1,603↑19.1% | 1,346↑6.7% | 1,262↓11.6% | 1,428↓40.0% | 2,381 | |
| Depreciation & Amortization | 570↑15.6% | 493↑12.3% | 439↑0.5% | 437↑7.1% | 408 | |
| EBITDA | 2,194↑15.8% | 1,894↑9.4% | 1,732↓4.8% | 1,820↓42.4% | 3,159 | |
| EBIT | 1,624↑15.9% | 1,401↑8.4% | 1,293↓6.5% | 1,383↓49.7% | 2,751 | |
| Interest & Other Income | ||||||
| Net Interest Income | -264↓31.3% | -201↓32.2% | -152↓10.1% | -138↑8.6% | -151 | |
| Interest Income | 0.00↓100.0% | 25↑127.3% | 11↑10.0% | 10↑900.0% | 1 | |
| Interest Expense | 264↑16.8% | 226↑38.7% | 163↑10.1% | 148↓2.6% | 152 | |
| Non-Operating Income | -21↑61.8% | -55↓77.4% | -31↓168.9% | 45↑112.2% | -370 | |
| Other Income / Expenses | -243↓59.9% | -152↓43.4% | -106↑28.9% | -149↓150.3% | 296 | |
| Income Before Tax | 1,360↑13.9% | 1,194↑3.3% | 1,156↓9.6% | 1,279↓52.2% | 2,677 | |
| Income Tax Expense | 314↑15.0% | 273↑10.1% | 248↓6.1% | 264↓55.8% | 597 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 1,046↑13.6% | 921↑1.4% | 908↓10.5% | 1,015↓51.2% | 2,080 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 992↑13.9% | 871↑2.0% | 854↓9.7% | 946↓52.6% | 1,995 | |
| Bottom-Line Net Income | 992↑14.5% | 866↑1.9% | 850↓9.8% | 942↓52.6% | 1,988 | |
| EPS (Basic) | 8.87↑13.7% | 7.80↑2.8% | 7.59↓6.5% | 8.12↓48.9% | 15.90 | |
| EPS (Diluted) | 8.75↑13.8% | 7.69↑2.3% | 7.52↓5.8% | 7.98↓48.6% | 15.53 | |
| Weighted Average Shares | 111↑0.0% | 111↓0.9% | 112↓3.4% | 116↓7.2% | 125 | |
| Weighted Average Diluted Shares | 113↑0.0% | 113↑0.0% | 113↓4.2% | 118↓7.8% | 128 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.